VITALIST INC (VITA.CA) Fundamental Analysis & Valuation

TSX-V:VITA • CA92847E1034

Current stock price

0.43 CAD
+0.01 (+1.18%)
Last:

This VITA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VITA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year VITA has reported negative net income.
  • In the past year VITA has reported a negative cash flow from operations.
VITA.CA Yearly Net Income VS EBIT VS OCF VS FCFVITA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • VITA has a Return On Assets of -294.54%. This is amonst the worse of the industry: VITA underperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA -294.54%
ROE N/A
ROIC N/A
ROA(3y)-473.88%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VITA.CA Yearly ROA, ROE, ROICVITA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • VITA has a worse Gross Margin (10.87%) than 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of VITA has grown nicely.
  • The Profit Margin and Operating Margin are not available for VITA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y105.25%
GM growth 5YN/A
VITA.CA Yearly Profit, Operating, Gross MarginsVITA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 100 -100 200 -200 -300

0

2. VITA.CA Health Analysis

2.1 Basic Checks

  • VITA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VITA has about the same amount of shares outstanding.
  • VITA has a worse debt/assets ratio than last year.
VITA.CA Yearly Shares OutstandingVITA.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M
VITA.CA Yearly Total Debt VS Total AssetsVITA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • VITA has an Altman-Z score of -68.63. This is a bad value and indicates that VITA is not financially healthy and even has some risk of bankruptcy.
  • VITA has a worse Altman-Z score (-68.63) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -68.63
ROIC/WACCN/A
WACC8.26%
VITA.CA Yearly LT Debt VS Equity VS FCFVITA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M -10M -15M -20M

2.3 Liquidity

  • VITA has a Current Ratio of 0.16. This is a bad value and indicates that VITA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of VITA (0.16) is worse than 80.00% of its industry peers.
  • VITA has a Quick Ratio of 0.16. This is a bad value and indicates that VITA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.16, VITA is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
VITA.CA Yearly Current Assets VS Current LiabilitesVITA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M 15M

1

3. VITA.CA Growth Analysis

3.1 Past

  • The earnings per share for VITA have decreased by -9.32% in the last year.
  • Looking at the last year, VITA shows a quite strong growth in Revenue. The Revenue has grown by 12.13% in the last year.
  • Measured over the past years, VITA shows a very negative growth in Revenue. The Revenue has been decreasing by -11.69% on average per year.
EPS 1Y (TTM)-9.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-159.04%
Revenue 1Y (TTM)12.13%
Revenue growth 3Y-11.69%
Revenue growth 5YN/A
Sales Q2Q%-46.8%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VITA.CA Yearly Revenue VS EstimatesVITA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2M 4M 6M

0

4. VITA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VITA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VITA.CA Price Earnings VS Forward Price EarningsVITA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VITA.CA Per share dataVITA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. VITA.CA Dividend Analysis

5.1 Amount

  • VITA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

VITA.CA Fundamentals: All Metrics, Ratios and Statistics

VITALIST INC

TSX-V:VITA (4/9/2026, 7:00:00 PM)

0.43

+0.01 (+1.18%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-12
Earnings (Next)07-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap21.96M
Revenue(TTM)5.13M
Net Income(TTM)-3.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.28
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.1
BVpS-0.26
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -294.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.87%
FCFM N/A
ROA(3y)-473.88%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y105.25%
GM growth 5YN/A
F-Score3
Asset Turnover3.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -68.63
F-Score3
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-159.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.13%
Revenue growth 3Y-11.69%
Revenue growth 5YN/A
Sales Q2Q%-46.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.43%
OCF growth 3YN/A
OCF growth 5YN/A

VITALIST INC / VITA.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VITALIST INC?

ChartMill assigns a fundamental rating of 1 / 10 to VITA.CA.


What is the valuation status of VITALIST INC (VITA.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to VITALIST INC (VITA.CA). This can be considered as Overvalued.


What is the profitability of VITA stock?

VITALIST INC (VITA.CA) has a profitability rating of 1 / 10.